Dukascopy issues warning over fraudulent website clone
Dukascopy issues warning over fraudulent website clone
Dukascopy, a prominent Swiss online bank and financial services provider, has issued a stark warning to its clients and the public regarding a fraudulent clone of its official website.
The company alerted users to the existence of a scam website https://dukasaitrades.eu/ that mimics the look and feel of Dukascopy’s legitimate platform in an attempt to deceive users and steal personal information.
In an official statement, Dukascopy clarified that the fraudulent website, identified as a clone, has been designed to resemble the bank's authentic site, but it is being used to mislead visitors into sharing sensitive data, including login credentials and financial details. The bank emphasized that it is not associated with the fake website in any capacity and has urged its clients to be cautious when accessing their accounts online.
The warning comes after the bank's security team identified this malicious activity and took immediate steps to alert authorities and the public. According to Dukascopy, the fraudulent website uses a similar domain name and visual design to trick users into believing they are on the legitimate platform. However, the clone is part of a broader scheme to harvest personal data and potentially commit financial fraud against unsuspecting users.
Dukascopy has advised all clients to remain vigilant and to verify the authenticity of any website they use by ensuring they are accessing the official Dukascopy domain. The bank recommended that users bookmark its official website or manually enter the URL into their browser to avoid being redirected to malicious sites. Additionally, clients are encouraged to report any suspicious activity they encounter to the company’s support team or the relevant financial authorities.
Read also: Octa launches October MT4 demo contest for aspiring traders
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
